| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |